<DOC>
	<DOCNO>NCT00560053</DOCNO>
	<brief_summary>The study objective investigate toxicity BUMEL response rate ; patient reach CR autotransplantation , investigate negativization IF , influence disease evolution ; patient PR autotransplantation , analyze second intensive procedure capable increase response rate increase survival patient reach CR first transplantation ; Patients MM primarily resistant chemotherapy , investigate efficacy double transplantation ; patient submit double transplantation , control efficacy second transplantation front allogenic transplantation .</brief_summary>
	<brief_title>Pethema Multiple Myeloma 2000</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Less 70 year ECOG 02 Symptomatic MM ( pain , anemia , infection , haemorrhage , loss weight , hypercalcemia , extramedulary plasmocytoma , creatinine &gt; 2 mg/dl ) . No previous chemotherapy &gt; 70 year ECOG 34 myeloma quiescent cardiopathy liver disfunction HIV+ Hepatitis BC + Previous chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Alternating chemotherapy</keyword>
	<keyword>Transplantation</keyword>
</DOC>